Vyome Holdings Inc (HIND): Operatsion rentabellik

Ommaviy kompaniya Vyome Therapeutics (HIND) logotipi

Vyome Holdings Inc (HIND) yirik miqyosda dori ishlab chiqarish uchun ishlab chiqarish ob'ektlarini modernizatsiya qilish bilan birga, inqilobiy terapiya usullarini yaratish uchun yetakchi immunologlarni birlashtiradi. Biznesning operatsion samaradorligi ushbu grafikda vizuallashtirilgan bo'lib, u joriy daromadlilikni aks ettiradi, bunda -2853.60 qiymati haqiqiy ko'rsatkichni bildiradi. Emitentning barqarorligi US markazlarida surunkli yallig'lanish va akne bilan kurashish uchun yangi molekulalarning ishlab chiqilishiga bog'liq.

HIND: Vyome Holdings Inc. Sotuvning operatsion rentabelligi 16.08.2025 - 20.11.2026

reshapelifesciences.com - tahliliy kesimlar va asosiy koʻrsatkichlar (HIND)

- narx va narxlar bo'yicha konsensus prognoz:
Kompaniyaning fundamental tahlili:HIND, ReShape Lifesciences
Vyome Holdings Inc tayyor mahsulotlari

Operatsion marja moliyaviy majburiyatlar va soliqlarni hisobga olgunga qadar asosiy operatsiyalardan olingan foyda ulushini aniqlash orqali xarajatlarni boshqarish samaradorligini o'lchaydi. Operatsion foyda marjasini tahlil qilish orqali investor biznesning barqarorligini baholashi mumkin, bu esa Vyome Holdings Inc (HIND) uchun immunofarmatsevtika sohasidagi strategik ittifoqlarning sinergiyasi va hamkor klinikalari orqali Lap-Band tizimlarining joriy etilishiga bevosita bog'liqdir.

Muhim raqobatchilar

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|CABA: Operatsion rentabellik|VTYX (Ventyx Biosciences, Inc.) - Sotuvning operatsion marjasi|THTX - Operatsion faoliyat rentabelligi|AVTX (avalotx.com) - Operatsion marja|Sotuvning operatsion rentabelligi Eledon Pharmaceuticals Inc. ELDN|Operatsion marja AGEN|CLYM (Climb Bio, Inc.) - Operatsion foyda normasi|Operatsion rentabellik zurabio.com ZURA|ATYR - Sotuvning operatsion marjasi|Adagene Inc - Operatsion marja|ImageneBio (IMA) - Sotuvning operatsion marjasi|Shattuck Therapeutics (STTK) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Equillium Inc (EQ)|Sotuvning operatsion marjasi CNTB|Operatsion foyda bo'yicha sotuv rentabelligi IMUX (Immunic, Inc.)|Operatsion rentabellik Atara Biotherapeutics, Inc. (ATRA)|IFRX - Sotuvning operatsion rentabelligi|Operatsion faoliyat rentabelligi XFOR|Operatsion faoliyat rentabelligi Adicet (ACET)|CELU - Operatsion rentabellik|INMB (INmune Bio, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|BRNS: Operatsion marja|Kezar Life Sciences Inc. (KZR) - Operatsion marja|Operatsion rentabellik SAB Biotherapeutics Inc|Operatsion marja Akari Therapeutics, Plc|Operatsion rentabellik Enlivex Therapeutics Ltd (ENLV)|QTTB - Sotuvning operatsion rentabelligi|Operatsion marja GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Sotuvning operatsion rentabelligi|iBio Corporation - Operatsion marja|CARM (carismatx.com) - Operatsion foyda bo'yicha sotuv rentabelligi|XTLB (XTL Bio) - Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Bolt Biotherapeutics Inc. (BOLT)|Sotuvning operatsion marjasi HCWB|Aptevo Therapeutics Inc. - Operatsion foyda marjasi|Operatsion rentabellik AIM ImmunoTech, Inc. (AIM)|Operatsion marja Aditxt Corp (ADTX)|Operatsion marja GRI (GRI Bio Corporation)|XORTX Therapeutics (XRTX) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com